The following prognostic factors significantly influenced the survival of the patients treated with combination of RT and chemotherapy : age ( p < 0.05 ) , performance status ( PS ) ( p < 0.001 ) , weight loss ( p < 0.001 ) , tumor size ( p < 0.05 ) , nodal involvement ( p < 0.05 ) .